Blue Buffalo, a natural pet food company, has appointed Amy Schulman to its board of directors.
Schulman is currently the CEO of Arsia Therapeutics, a venture partner at Polaris Ventures, and a senior lecturer at Harvard Business School.
Prior to these roles, Schulman was general counsel of Pfizer from 2008 to 2013 and saw the company through its $68 billion acquisition of Wyeth. In addition to this role, Schulman became the president and general manager of Pfizer's global infant formula and nutrition business in 2010. After she led the sale of that business to Nestle in 2012, she assumed the responsibility for Pfizer's Consumer Healthcare business.